Member Info for Grifter

Air France-KLM CEO signals willingness to engage in talks on possible easyJet bid | NL Times https://nltimes.nl/2026/06/07/air-france-klm-ceo-signals-willingness-engage-talks-possible-easyjet-bid

Air France-KLM CEO signals willingness to engage in talks on possible easyJet bid | NL Times https://nltimes.nl/2026/06/07/air-france-klm-ceo-signals-willingness-engage-talks-possible-easyjet-bid

Air France-KLM CEO signals willingness to engage in talks on possible easyJet bid | NL Times https://nltimes.nl/2026/06/07/air-france-klm-ceo-signals-willingness-engage-talks-possible-easyjet-bid

Institutional buying?

They have already tried to get swift approval for the UK and got rejected once then dropped it for the foreseeable future.

Could do with a director buy to stabilise the price at this level.

In spite of the retrace, recent newsflow has been better and website resign indicates a change of attitude at the company. If people think this website is amateur. The need to acknowledge the old website was a lot worse, so it's progress nonetheless.

There is renewed potential. The question remains, how much?

Think we are approaching fair value.

The two recent announcements will be revenue and cash generative in the next 18 months - if the bank deal is approved.

There seems to be a strategy in place to work in higher margin businesses and to replace older revenue streams that may no longer have growth potential.

The Bangladesh deal is about to go live and is not subject to due diligence.

If next year's results look upbeat as a consequence this could go a lot higher.

TETE, if it ever completes would be a bonus, but is no longer the only iron in MPBO's fire.

Growth is where it's at and will handsomely reward investors if achieved.

Think we just reached fa

I think the next positive news will be an update on the Islamic bank. That may be several months down the line. If positive, it could send the share price a lot higher than current levels/range.

5 million plus.

Shut up ramping child.

There is no logic to that as he could do the same without the merger. All he needs to do is award himself so many options at the right price.

Future fund raising is key for me as if done via a placing would be dilutive. Personally, I prefer the Dragon's Den approach of selling a stake in companies to fund raise although that doesn't cover the admin costs of running Tern, that despite synergies, will still be needed and that's what we now need clarification on.

He's probably down an out with the share price and general market sentiment. Sure he has a lot riding on ITM as well as punters.

It's a late reported trade. Has no impact on closing price.

Closed €7.75 = £6.91.

Your guess is as good as mine, but I expect they were sounding out institutions. Then switched to plan B.

Likely because they could not find a partner quickly and decided they needed to go it alone otherwise the therapy might be out of date when approved.

Their share price looks tasty as well. https://m.uk.investing.com/equities/parexel-international

Parexel Biotech Collaborates with Synairgen on Pivotal Phase III Trial for Study of Inhaled COVID-19 Treatment
Synairgen selects Parexel Biotech for global study to evaluate interferon beta compound

https://www.globenewswire.com/news-release/2020/10/20/2110915/0/en/Parexel-Biotech-Collaborates-with-Synairgen-on-Pivotal-Phase-III-Trial-for-Study-of-Inhaled-COVID-19-Treatment.html